Healthcare lobbyists holding off on “all-out warfare” on ACA repeal

The healthcare industry has appeared to be united in opposition to the Republican-sponsored American Health Care Act (AHCA), but Vox reports industry lobbyists are stomaching the legislation in an attempt to maintain good relations with a Republican Congress and president.

The thinking is mounting a big fight against the AHCA could shut healthcare companies out of discussions on other issues, like tax cuts. Another factor, according to Vox, is the industry “doesn’t love Obamacare enough” to fight against its repeal.

But that doesn’t mean they want to see the AHCA become law, either.

“I think industry is holding back in the Senate out of a belief that this may collapse largely on its own,” one Republican healthcare lobbyist said, “and out of concern for how Trump might retaliate if industry is perceived as killing it.”

Publicly, however, many groups, like the American Medical Association, have been bashing the bill both through advocacy in Washington and at their own conferences.

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.